Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP532840.RAxyXBlHr2gHXI7XZCaVRdaeS6TwbaHNI0fZ79gx1IksU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP532840.RAxyXBlHr2gHXI7XZCaVRdaeS6TwbaHNI0fZ79gx1IksU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP532840.RAxyXBlHr2gHXI7XZCaVRdaeS6TwbaHNI0fZ79gx1IksU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP532840.RAxyXBlHr2gHXI7XZCaVRdaeS6TwbaHNI0fZ79gx1IksU130_provenance.
- NP532840.RAxyXBlHr2gHXI7XZCaVRdaeS6TwbaHNI0fZ79gx1IksU130_assertion description "[Two patients with FSCCL, 22 patients with DSCCL, and all of the patients with MZL had a phenotype of mantle zone (MZ) B-lymphocytes (SIgD+, Leu-1+, Leu-8+, positive alkaline phosphatase [ALPase+], and negative common acute lymphoblastic leukemia antigen [CALLA-]), and all the tested patients (2 patients with FSCCL, 13 patients with DSCCL, and 4 patients with MZL) had germlines of bcl-2 gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP532840.RAxyXBlHr2gHXI7XZCaVRdaeS6TwbaHNI0fZ79gx1IksU130_provenance.
- NP532840.RAxyXBlHr2gHXI7XZCaVRdaeS6TwbaHNI0fZ79gx1IksU130_assertion evidence source_evidence_literature NP532840.RAxyXBlHr2gHXI7XZCaVRdaeS6TwbaHNI0fZ79gx1IksU130_provenance.
- NP532840.RAxyXBlHr2gHXI7XZCaVRdaeS6TwbaHNI0fZ79gx1IksU130_assertion SIO_000772 1643614 NP532840.RAxyXBlHr2gHXI7XZCaVRdaeS6TwbaHNI0fZ79gx1IksU130_provenance.
- NP532840.RAxyXBlHr2gHXI7XZCaVRdaeS6TwbaHNI0fZ79gx1IksU130_assertion wasDerivedFrom befree-2016 NP532840.RAxyXBlHr2gHXI7XZCaVRdaeS6TwbaHNI0fZ79gx1IksU130_provenance.
- NP532840.RAxyXBlHr2gHXI7XZCaVRdaeS6TwbaHNI0fZ79gx1IksU130_assertion wasGeneratedBy ECO_0000203 NP532840.RAxyXBlHr2gHXI7XZCaVRdaeS6TwbaHNI0fZ79gx1IksU130_provenance.
- befree-2016 importedOn "2016-02-19" NP532840.RAxyXBlHr2gHXI7XZCaVRdaeS6TwbaHNI0fZ79gx1IksU130_provenance.